BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22940730)

  • 21. [Malignant lymphoma of the skin].
    Nakajima H; Miyamoto H
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized cutaneous T cell lymphoma presenting as disfiguring facial lesions.
    Kaliyadan F; Jayasree MG; Unni M; Neeraj S
    Dermatol Online J; 2009 Nov; 15(11):14. PubMed ID: 19951650
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.
    Csomor J; Bognár A; Benedek S; Sinkó J; Fekete S; Krenács L; Matolcsy A; Reiniger L
    J Clin Pathol; 2008 Jun; 61(6):770-2. PubMed ID: 18505891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cutaneous B-cell lymphoma with aggressive clinical presentation: apropos of a case].
    Grau E; Real E; Perella M; Escandon J; Pastor E; Gómez A
    Sangre (Barc); 1997 Jun; 42(3):231-3. PubMed ID: 9381268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques.
    Xu H; Qian J; Wei J; Zhao Y; Zhou C; Chen D; Zhang J
    Eur J Dermatol; 2011; 21(4):609-10. PubMed ID: 21680287
    [No Abstract]   [Full Text] [Related]  

  • 28. T-cell lymphoma presenting as a rapidly enlarging tumor on the lower eyelid.
    Onesti MG; Mazzocchi M; De Leo A; Scuderi N
    Acta Chir Plast; 2005; 47(3):65-6. PubMed ID: 16173513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
    Isogai R; Fukao M; Kawada A
    J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
    Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
    Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous panniculitislike T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol.
    Medhi K; Kumar R; Rishi A; Kumar L; Bakhshi S
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):558-61. PubMed ID: 18797207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
    Kost Al M; Kost Alová M; Belada D; Laco J
    Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
    Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
    Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggressive lymphoma involving intracranial epidural region.
    Villela LM; Blanco-Salazar A; Caballero R; Borbolla-Escoboza R
    J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
    Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
    Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
    [No Abstract]   [Full Text] [Related]  

  • 37. Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.
    Ingram RM; Williams ME; Fintel WA; Ross M
    Clin Lymphoma; 2002 Mar; 2(4):238-41. PubMed ID: 11970763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous manifestations of T-cell prolymphocytic leukemia].
    De Belilovsky C; Guillaume JC; Gilles E; Bosq J; Hayat M; Desvignes V; Avril MF
    Ann Dermatol Venereol; 1989; 116(11):889-91. PubMed ID: 2619197
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.